Hadley, Massachusetts (January 7th, 2025) – Clarifies Position Following Court Ruling and Highlights Proactive Measures in Product Development
American River Nutrition, LLC (ARN) has prevailed in their defense against Kaneka Corporation in a ruling relating to infringement of Kaneka’s U.S. Patent No. 7,829,080 filed in 2021 in the U.S. District Court for the District of Delaware. The Court found ARN not liable for induced or willful infringement, the only claims Kaneka brought against ARN in the case.
ARN continues to market its innovative active form of coenzyme Q10 (CoQ10), ubiquinol-based product under the brand name ProQnolTM. Commenting on the case, Mr. Keith Dunne, General Manager of ARN noted, “ARN reformulated the product in 2023 to address concerns raised in the case. We are committed to strengthening the research and evidence base surrounding our ProQnolTM product to better serve our customers and partners. ProQnol™ is a patented, next-generation ubiquinol. This groundbreaking technology uses a natural solubilizer to transform (CoQ10) ubiquinone into the active form of CoQ10 (ubiquinol)”
ARN will continue to advance its mission of delivering innovative, high-quality products while maintaining a strong focus on intellectual property and scientific integrity.
About American River Nutrition (ARN)
American River Nutrition (ARN) was founded in 1998 by Dr. Barrie Tan and is located in Hadley, MA. ARN’s mission focuses on advancing human health through science-based innovation of functional ingredients. ARN manufactures its products in Massachusetts at its state-of-art, GMP compliant, 24,000 square foot facility using a range of proprietary processes and technologies. To learn more, visit http://americanrivernutrition.com/
Media Contact:
Jenn Wilson
jwilson@american-river.com
